ATRX and neoplasm: To this end, we used flow cytometry to analyze dissociated AtrxWT and Atrx-KO CT2A tumor-bearing brain hemispheres from immunocompetent mice 14 days after intracranial implantation (Fig. 4a; Supplementary Fig. 6).